Bayer (Cell Therapy Mfg)

NCT07282847 A Study to Evaluate Safety, Tolerability, and Efficacy of AB-1009 Gene... PHASE1/PHASE2 Recruiting NCT06944522 A Study to Investigate the Efficacy and Safety of Bemdaneprocel in Adults... PHASE3 Recruiting NCT06914128 A First-in-human Study to Learn How Safe BAY 3713372 is and How it Works in... PHASE1/PHASE2 Recruiting NCT06452277 A Study to Learn More About How Well Sevabertinib Works and How Safe it is... PHASE3 Recruiting NCT06285643 A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD) PHASE2 Recruiting NCT04777851 Regorafenib-pembrolizumab vs. TACE/TARE in Intermediate Stage HCC Beyond Up-to-7 PHASE3 Terminated NCT05617885 Neo-DAB: Darolutamide and Abemaciclib in Prostate Cancer PHASE1 Active Not Recruiting NCT05537740 A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an... PHASE1 Active Not Recruiting NCT05236257 A Study Called EPI VITRAKVI to Compare Treatment Results in Patients With... NA Completed NCT04572763 Copanlisib Plus Venetoclax in R/R DLBCL PHASE1/PHASE2 Active Not Recruiting NCT04999202 A Study to Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in... PHASE1 Terminated NCT04803123 Window Trial to Evaluate Molecular Response to PI3K Inhibition With... EARLY_PHASE1 Terminated NCT04879368 RegoNivo vs Standard of Care Chemotherapy in AGOC PHASE3 Active Not Recruiting NCT04895579 Lung Cancer With Copanlisib and Durvalumab PHASE1 Completed NCT04704154 A Trial to Learn Whether Regorafenib in Combination With Nivolumab Can... PHASE2 Completed NCT04476329 Optimization for Regorafenib in HCC PHASE2 Terminated NCT04025372 INTREPId (INTermediate Risk Erection PreservatIon Trial) PHASE2 Active Not Recruiting NCT04156828 Copanlisib and Combination Chemotherapy for the Treatment of Relapsed or... PHASE1 Terminated NCT04233697 Copanlisib in Combination With Romidepsin in Patients With Relapsed or... PHASE1 Withdrawn NCT04040725 Rogaratinib for BCG Refractory High Risk Non-Muscle Invasive Bladder Cancer... PHASE2 Withdrawn